Hutch News

Hutch News

Stories tagged 'Melanoma'

5 tips for a healthy summer (and life)!

From bench to beachside: Empower yourself with evidenced-based cancer-prevention science

June 29, 2018 | By Diane Mapes / Fred Hutch News Service

Want to make this your healthiest summer yet? Empower yourself — and your loved ones — with some disease-squelching science and practical prevention tips from Fred Hutch public health researchers.

View story >


His immune system eradicated his melanoma. Could other patients’ bodies be taught to do the same thing?

How one man’s T cells are guiding the development of next-gen immunotherapies

June 19, 2018 | by Susan Keown / Fred Hutch News Service

Chris Pope's immune system eradicated his stage 4 melanoma on an immunotherapy clinical trial. Is it possible to genetically reprogram other patients' to do the same thing?

View story >


Immune cells share their insides with tumors to promote cancer spread

New study in zebrafish and mice shows immune cells interact with melanoma and transfer their contents to spur metastasis

Dec. 4, 2017 | By Rachel Tompa / Fred Hutch News Service

A new study using mice and tiny transparent fish as models of human cancer, published in Developmental Cell, has shed light on the very first stages of metastasis in the skin cancer melanoma.

View story >


7 skin cancer myths — debunked

Experts take on base tans and other ‘complete baloney’ standing in the way of skin health

Aug. 2, 2017 | By Susan Keown / Fred Hutch News Service

From indoor tanning to sunscreen use: Lower your risk of skin cancer by confronting these myths head on.

View story >


Forum at Fred Hutch focuses on the hottest developments in cancer immunotherapy

Immune-based treatments move from the fringes to the spotlight

June 16, 2017 | By Susan Keown / Fred Hutch News Service

What's new in cancer immunotherapy? Five hot topics, from new combination therapies to cost.

View story >


Dissolving implant could bring immunotherapy to solid tumors

A biopolymer sponge delivers cancer-shrinking T-cell therapy in preclinical study

April 24, 2017 | By Sabrina Richards / Fred Hutch News Service

A dissolving scaffold developed by Dr. Matthias Stephan delivers engineered anti-tumor immune cells to crowded masses of tumor cells and recruits the native immune system to mount a second-wave attack on the cancer.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.